Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. A1elk
2. Us5q3kd5rd
3. Schembl24295512
4. Ex-a11619
5. Hy-160929
6. Cs-1052169
7. 1,2,4-oxadiazol-5(2h)-one, 3-(4-(3-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)-8-azabicyclo(3.2.1)oct-8-yl)-2-fluorophenyl)-
8. 2765593-43-7
| Molecular Weight | 571.4 g/mol |
|---|---|
| Molecular Formula | C28H25Cl2FN4O4 |
| XLogP3 | 6.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 89.2 |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 935 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
79
PharmaCompass offers a list of Linafexor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Linafexor manufacturer or Linafexor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Linafexor manufacturer or Linafexor supplier.
A Linafexor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Linafexor, including repackagers and relabelers. The FDA regulates Linafexor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Linafexor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Linafexor supplier is an individual or a company that provides Linafexor active pharmaceutical ingredient (API) or Linafexor finished formulations upon request. The Linafexor suppliers may include Linafexor API manufacturers, exporters, distributors and traders.
Linafexor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Linafexor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Linafexor GMP manufacturer or Linafexor GMP API supplier for your needs.
A Linafexor CoA (Certificate of Analysis) is a formal document that attests to Linafexor's compliance with Linafexor specifications and serves as a tool for batch-level quality control.
Linafexor CoA mostly includes findings from lab analyses of a specific batch. For each Linafexor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Linafexor may be tested according to a variety of international standards, such as European Pharmacopoeia (Linafexor EP), Linafexor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Linafexor USP).
